An observational study in Hernia Abdominal Wall and Laparoscopic, sponsored by Sohag University. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-28.
Sponsored by Sohag University · Observational
evaluate the clinical experience of Sohag University Hospital with laparoscopic intraperitoneal onlay mesh repair for ventral hernias, assessing operative feasibility, intraoperative complications, postoperative recovery and short-term surgical outcomes, in order to determine its safety and effectiveness in a regional setting.
The present study aims to evaluate the clinical experience of Sohag University Hospital with laparoscopic intraperitoneal onlay mesh repair for ventral hernias, assessing operative feasibility, intraoperative complications, postoperative recovery and short-term surgical outcomes, in order to determine its safety and effectiveness in a regional setting.
82 studies on the registry are indexed under Hernia, Abdominal; 19 are open to participants now.
This study's planned enrollment of 30 is below the median of 115 across 29 observational studies indexed under Hernia, Abdominal.
Browse Hernia, Abdominal studies →Sohag University is the lead sponsor of 1,230 studies on the registry; 636 are open to participants now.
Counted across the registry records on this site, refreshed daily.
The study will include adult patients with primary ventral hernias who are eligible for elective laparoscopic ventral hernia repair using the IPOM technique
Adult patients aged 18 years or older. Patients diagnosed clinically and/or radiologically with primary ventral hernia.
Patients planned for elective laparoscopic ventral hernia repair using the IPOM technique.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
1. Adult patients aged 18 years or older. 2. Patients diagnosed clinically and/or radiologically with primary ventral hernia. 3. Patients planned for elective laparoscopic ventral hernia repair using the IPOM technique.
the safety and effectiveness of laparoscopic IPOM repair for ventral hernia,
The primary outcome will be the safety and effectiveness of laparoscopic IPOM repair for ventral hernia, assessed by postoperative complication rate during the follow-up period.
Time frame: 3 months
No study locations are listed for this record.
Plan to share: Undecided
No publications or documents are linked to this record.
Start is estimated for Aug 2026; primary completion for Jan 2027, 5 months later.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.